2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $2B | $2.4B | $2.6B | $2.8B | $2.7B |
Cost of Revenue | $1.3B | $1.6B | $1.7B | $1.8B | $1.7B |
Gross Profit | $682M | $838M | $886M | $1B | $1B |
Gross Profit % | 35% | 35% | 34% | 37% | 38% |
R&D Expenses | $35M | $40M | $36M | $39M | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | $160M | $239M | $228M | $216M | $271M |
Dep. & Amort. | $77M | $76M | $66M | $70M | $67M |
Def. Tax | -$14M | -$8.6M | -$20M | -$25M | -$2.6M |
Stock Comp. | $6.4M | $6.3M | $13M | $16M | $20M |
Chg. in WC | $84M | -$50M | -$65M | $53M | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $49M | $41M | $72M | $102M | $249M |
ST Investments | $0 | $0 | $0 | $0 | $0 |
Cash & ST Inv. | $49M | $41M | $72M | $102M | $249M |
Receivables | $330M | $383M | $374M | $385M | $0 |
Inventory | $313M | $420M | $417M | $393M | $404M |
ESAB achieved record fourth-quarter adjusted EBITDA margin of 20.3% and a full-year margin of 19.7%, driven by continuous improvement initiatives and strong cash flow generation.
The company provided 2025 guidance, expecting organic growth of 0%-2%, adjusted EBITDA between $515M-$530M, and approximately $25M in savings from productivity and cost reduction initiatives.
ESAB plans to invest in growth initiatives, including AI, new product development, and commercial excellence programs, while continuing to optimize its manufacturing footprint and back-office operations.
The company completed three acquisitions in 2024 and announced its first deal for 2025, with all acquisitions expected to be EPS accretive in year one.
ESAB anticipates continued strength in high-growth markets like India and Southeast Asia, with stabilization and improvement in developed markets expected in the second half of 2025.